SC Pharmaceuticals Inc (SCPH)
2.69 x 5 3.59 x 4
Pre-market by (Cboe BZX)
3.00 -0.13 (-4.15%) 03/25/25 [NASDAQ]
2.69 x 5 3.59 x 4
Pre-market 3.00 unch (unch) 16:00 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 75,655 | 91,484 | 38,504 | 58,447 | 46,814 |
Marketable Securities | N/A | N/A | N/A | N/A | 29,199 |
Receivables | 11,721 | 9,217 | 6,116 | 5,772 | 4,489 |
Inventories | 13,903 | 18,107 | 15,308 | 9,572 | 8,840 |
Other current assets | 1,021 | 1,148 | 373 | 536 | 1,160 |
TOTAL | $105,849 | $123,329 | $62,631 | $76,525 | $92,938 |
Non-Current Assets | |||||
PPE Net | 56 | 51 | 47 | 52 | 58 |
Other Non-Current Assets | 1,614 | 1,689 | 2,780 | 1,877 | 1,483 |
TOTAL | $1,670 | $1,740 | $2,827 | $1,929 | $1,541 |
Total Assets | $107,519 | $125,069 | $65,458 | $78,454 | $94,479 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 3,883 | 5,003 | 5,294 | 2,706 | 4,001 |
Accrued Expenses | 10,702 | 9,868 | 7,399 | 9,206 | 8,901 |
Other current liabilities | 52 | 162 | 47 | 222 | 56 |
TOTAL | $14,876 | $15,264 | $12,930 | $12,318 | $13,134 |
Non-Current Liabilities | |||||
Long Term Debt | 51,350 | 51,099 | 39,990 | 39,385 | 38,811 |
aiOther Non-Current Liabilities | 27,973 | 27,997 | 3,288 | 2,185 | 5,316 |
TOTAL | $79,323 | $79,096 | $43,278 | $41,570 | $44,127 |
Total Liabilities | $94,199 | $94,360 | $56,208 | $53,888 | $57,261 |
Shareholders' Equity | |||||
Shares Outstanding, K | 50,284 | 50,040 | 50,029 | 36,054 | 36,054 |
Common Shares | 5 | 5 | 4 | 4 | 4 |
Retained earnings | -366,494 | -347,649 | -312,544 | -295,454 | -281,347 |
TOTAL | $13,320 | $30,709 | $9,250 | $24,566 | $37,218 |
Total Liabilities And Equity | $107,519 | $125,069 | $65,458 | $78,454 | $94,479 |